Olanzapine-induced "restless arms syndrome"

Journal of Clinical Psychopharmacology

Volumn 29, Issue 1, 2009, Pages 89-90

  Konstantakopoulos, George ^a   Oulis, Panagiotis ^a   Michalopoulou, Panayiota G ^a,b   Papadimitriou, George N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; OLANZAPINE; RISPERIDONE; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; AKATHISIA; CASE REPORT; DIZZINESS; DOPAMINERGIC SYSTEM; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSESTHESIA; FAMILY HISTORY; HUMAN; LETTER; MALE; PARANOID SCHIZOPHRENIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTLESS ARMS SYNDROME; RESTLESS LEGS SYNDROME; ARM; CHEMICALLY INDUCED DISORDER; PARESTHESIA; SCHIZOPHRENIA; SLEEP DISORDER;

ANTIPSYCHOTIC AGENTS; ARM; BENZODIAZEPINES; HUMANS; MALE; PARESTHESIA; SCHIZOPHRENIA; SLEEP DISORDERS; YOUNG ADULT;

EID: 62649116584     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31819302a0     Document Type: Letter

References (17)

1. Michaud M, Chabli A, Lavigne G, et al. Arm restlessness in patients with restless legs syndrome. Mov Disord. 2000;15:289-293.
2. Freedom T, Merchut MP. Arm restlessness as the initial symptom in restless legs syndrome. Arch Neurol. 2003;60:1013-1015.
3. Webb AT. Restless arms syndrome. JAMA. 1976;236:822.
4. Horvath J, Landis T, Burkhard PR. Restless arms. Lancet. 2008;371:530.
5. Kraus T, Schuld A, Pollmäher T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol. 1999;19:478-479.
6. Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry. 2002;35:109-111.
7. Pinninti NR, Mago R, Townsend J, et al. Periodic restless legs syndrome associated with quetiapine use. J Clin Psychopharmacol. 2005;25:617-618.
8. Duggal HS, Mendhekar DN. Clozapine-associated restless legs syndrome. J Clin Psychopharmacol. 2007;27:89-90.
9. Walters AS, Hening W, Chokroverty S, et al. Restlessness of the arms as the principal manifestation of neuroleptic-induced akathisia. J Neurol. 1989;236:435.
10. Walters AS, Hening W, Rubinstein M, et al. A clinical and polysomnographic comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome. Sleep. 1991;14:339-345.
11. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med. 2003;4:101-119.
12. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
13. Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med. 2004;5:385-391.
14. 2 receptor occupancy of olanzapine in schizophrenia: A PET investigation. Am J Psychiatry. 1998;155:921-928.
15. Markkula J, Lauerma H. Mianserin and restless legs. Int Clin Psychopharmacol. 1997;12:53-58.
16. Bahk WM, Pae CU, Chae JH, et al. Mirtazapine may have the propensity for developing a restless legs syndrome? A case report. Psychiatry Clin Neurosci. 2002;56:209-210.
17. Jacobs BL, Martín-Cora FJ, Formal CA. Activity of medullary serotonergic neurons in freely moving animals. Brain Res Brain Res Rev. 2002;40:45-52.